<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7367788\results\search\zoonosis\results.xml">
  <result pre="RepCurrent Pharmacology Reports2198-641XSpringer International PublishingCham pmcid: 7367788226 doi: 10.1007/s40495-020-00226-5 :" exact="Covid-19" post="(ATY Lau and A Kong, Section Editors) Pipeline Pharmacological"/>
  <result pre="the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for causing" exact="coronavirus disease 2019" post="(COVID-19), marked the third time in the twenty-first century"/>
  <result pre="to other parts of the world. This quick spread of" exact="SARS-CoV-2 infection" post="to many states across the globe affecting many people"/>
  <result pre="FDA-approved drugs or vaccines are available to treat or prevent" exact="SARS-CoV-2 infection." post="The current therapeutic options for COVID-19 are limited only"/>
  <result pre="severe acute respiratory syndrome (SARS) in 2002 and 2003 and" exact="Middle East respiratory syndrome" post="(MERS) in 2012 when a highly pathogenic coronavirus of"/>
  <result pre="of immunologically directed strategies and anti-cytokine therapy is indispensable in" exact="SARS-CoV-2 infection" post="as a notable proportion of COVID-19 patients have reported"/>
  <result pre="of ACEI, ARBs, and rbACE2 will increase or alleviate the" exact="SARS-CoV-2 infection." post="Another approach for reducing the impact of COVID-19 pandemic"/>
  <result pre="inhibiting viral replication and viral RNA synthesis Investigational drug for" exact="Ebola" post="virus and variety of RNA viruses; FDA Emergency Use"/>
  <result pre="other patients Investigational approach tried for emerging Infectious Diseases like" exact="Ebola" post="virus Anakinra (recombinant interleukin, immunotherapy) Phase 2/3 Target Interleukin-1"/>
  <result pre="combination with antiviral) Phase 3 Inhibit cyclo-oxygenase 2 (COX-2) and" exact="Influenza" post="A virus nucleoprotein (NP), reduces inflammation Osteoarthritis, rheumatoid arthritis,"/>
  <result pre="has shown anti-viral activity for various RNA viruses including the" exact="Ebola" post="virus and oseltamivir-resistant influenza virus [26]. It is a"/>
  <result pre="In India, HCQ is used as a prophylactic drug for" exact="SARS-CoV-2 infection" post="in healthcare professionals. Recently, the results of a most"/>
  <result pre="cytokines has been reported to correlate with disease severity in" exact="SARS-CoV-2 infection," post="and it might lead to acute lung injury, acute"/>
  <result pre="to COVID-19 patients to increase the ability to fight to" exact="SARS-CoV-2 infection." post="Another cell-based therapy that has shown promising results in"/>
  <result pre="the ACE2 receptor and exerting an antiviral effect to prevent" exact="SARS-CoV-2 infection" post="[70]. Medical institutions in China have published many TCM"/>
  <result pre="pandemics. This article is part of the Topical Collection on" exact="Covid-19" post="Publisherâ€™s Note Springer Nature remains neutral with regard to"/>
  <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the experience of clinical immunologists from ChinaClin Immunol202021415"/>
  <result pre="infectionProc Natl Acad Sci20201176771677632054787 17.ProschanMPhDMukadiDManzoMLPhDNzoloDet al.A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics SabueN Engl J Med20193812293230331774950 18.BrownAJWonJJGrahamRLDinnonKHSimsACFengJYet al.Broad"/>
  <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother2014584875488424841269 34.CaoBWangYWenDLiuWWangJFanGRuanLSongBCaiYWeiMLiXXiaJChenNXiangJYuTBaiTXieXZhangLLiCYuanYChenHLiHHuangHTuSGongFLiuYWeiYDongCZhouFGuXXuJLiuZZhangYLiHShangLWangKLiKZhouXDongXQuZLuSHuXRuanSLuoSWuJPengLChengFPanLZouJJiaCWangJLiuXWangSWuXGeQHeJZhanHQiuFGuoLHuangCJakiTHaydenFGHorbyPWZhangDWangCA trial"/>
  <result pre="J Med20073571450145117914053 48.Van GriensvenJEdwardsTDe LamballerieXSempleMGGallianPBaizeSet al.Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med2016374334226735992 49.RinaldoCRPassive immunization"/>
  <result pre="10.1007/s00134-020-05991-x. 56.RamanathanKAntogniniDCombesAPadenMZakharyBOginoMet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet.202039550751332007143 57.Wu C, Chen"/>
  <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, China. JAMA Intern Med. 2020:1â€&quot;24. 58.Liu"/>
  <result pre="Z, et al. The potential role of IL-6 in monitoring" exact="coronavirus disease 2019." post="medRxiv. 2020;10.1101/2020.03.01.20029769. 59.Xu X, Han M, Li T, Sun"/>
 </snippets>
</snippetsTree>
